These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11761989

  • 1. [Hepatitis C virus-related hepatocellular carcinoma].
    Sumi H, Yokosuka O.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():440-5. PubMed ID: 11761989
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
    Nagoshi S, Fujiwara K.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
    [No Abstract] [Full Text] [Related]

  • 4. [A small-sized hepatocellular carcinoma].
    Barbare JC.
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Radical and multimodality therapy for hepatitis C virus-related hepatocellular carcinoma].
    Ikeda K.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):821-7. PubMed ID: 7563883
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of hepatocellular carcinoma.
    Del Pozo AC, López P.
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [Abstract] [Full Text] [Related]

  • 10. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM, Sala M, Bruix J.
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
    Brechot C.
    Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of hepatocellular carcinoma in homozygous β-thalassemia cirrhotic patients.
    Gomatos IP, Alexakis N, Koskinas J, Smparounis SA, Katsaragakis S, Konstadoulakis MM, Zografos GC.
    Am Surg; 2013 Jan; 79(1):111-3. PubMed ID: 23317624
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Approaches for interventional therapy of hepatoma].
    Guan YS, Yang L.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):785. PubMed ID: 16248956
    [No Abstract] [Full Text] [Related]

  • 17. [The principle of interventional therapy of hepatoma].
    Zhao JN.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):784. PubMed ID: 16248955
    [No Abstract] [Full Text] [Related]

  • 18. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW, Park JW, Choi JI, Kim TH, Kim SH, Park HS, Lee WJ, Park SJ, Hong EK, Kim CM.
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [Abstract] [Full Text] [Related]

  • 19. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H, Omata M.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.